Amundi’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Sell
13,575
-2,716
-17% -$75.5K ﹤0.01% 1745
2026
Q1
$305K Buy
+16,291
New +$311K ﹤0.01% 1739
2025
Q4
Sell
-9,346
Closed -$251K 1895
2025
Q3
$251K Buy
+9,346
New +$223K ﹤0.01% 1494
2025
Q2
Sell
-19,809
Closed -$345K 2116
2025
Q1
$345K Sell
19,809
-3,976
-17% -$79.8K ﹤0.01% 1575
2024
Q4
$550K Buy
23,785
+15,128
+175% +$432K ﹤0.01% 1547
2024
Q3
$272K Buy
8,657
+1,330
+18% +$49.6K ﹤0.01% 1583
2024
Q2
$316K Buy
+7,327
New +$321K ﹤0.01% 1462
2023
Q3
Sell
-2,337
Closed -$122K 2062
2023
Q2
$122K Hold
2,337
﹤0.01% 1728
2023
Q1
$144K Buy
2,337
+637
+37% +$41.6K ﹤0.01% 1656
2022
Q4
$117K Sell
1,700
-148
-8% -$9.28K ﹤0.01% 1583
2022
Q3
$137K Hold
1,848
﹤0.01% 1510
2022
Q2
$135K Hold
1,848
﹤0.01% 1406
2022
Q1
$134K Sell
1,848
-1,087
-37% -$81K ﹤0.01% 1429
2021
Q4
$222K Hold
2,935
﹤0.01% 1479
2021
Q3
$377K Buy
2,935
+559
+24% +$78.2K ﹤0.01% 1380
2021
Q2
$362K Buy
+2,376
New +$313K ﹤0.01% 1302

Other funds holding STAA

Amundi's STAA Position: Q2 2026 in Review

Amundi reduced its STAAR Surgical (STAA) stake by 17% in Q2 2026, selling an estimated $75.5K and leaving 13,575 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Amundi first reported a position in STAA in Q2 2021 and has held it in 16 quarters since. The position peaked at $550K in Q4 2024. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Amundi held 13,575 shares of STAAR Surgical worth $389K as of Q2 2026.
  • Amundi sold 2,716 STAAR Surgical shares in Q2 2026, an estimated $75.5K.
  • STAAR Surgical made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1745 holding.
  • Amundi first reported a position in STAAR Surgical in Q2 2021 and has held it in 16 quarters since.
  • Amundi's STAAR Surgical position peaked at $550K in Q4 2024.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.